|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5580 EUR | -2.11% |
|
-13.49% | -63.67% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AB SCIENCE | Specialty & Advanced Pharmaceuticals | -2.11% | -13.49% | -63.67% | -53.50% | -96.21% | 52.03M |  | | |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
